Group One Trading’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-25,332
| Closed | -$478K | – | 5976 |
|
|
2019
Q3 | $478K | Buy |
25,332
+24,160
| +2,061% | +$276K | ﹤0.01% | 2374 |
|
|
2019
Q2 | $14K | Buy |
1,172
+500
| +74% | +$6.05K | ﹤0.01% | 4325 |
|
|
2019
Q1 | $9K | Sell |
672
-4,283
| -86% | -$55.5K | ﹤0.01% | 4329 |
|
|
2018
Q4 | $51K | Sell |
4,955
-1,200
| -19% | -$15.4K | ﹤0.01% | 3559 |
|
|
2018
Q3 | $102K | Buy |
6,155
+847
| +16% | +$15.3K | ﹤0.01% | 3524 |
|
|
2018
Q2 | $84K | Sell |
5,308
-3,537
| -40% | -$53.7K | ﹤0.01% | 3673 |
|
|
2018
Q1 | $112K | Buy |
8,845
+1,568
| +22% | +$22.7K | ﹤0.01% | 3177 |
|
|
2017
Q4 | $83K | Sell |
7,277
-20,020
| -73% | -$223K | ﹤0.01% | 3467 |
|
|
2017
Q3 | $334K | Buy |
27,297
+2,404
| +10% | +$25.1K | ﹤0.01% | 2377 |
|
|
2017
Q2 | $285K | Buy |
+24,893
| New | +$460K | ﹤0.01% | 2387 |
|
|
2016
Q4 | – | Sell |
-853
| Closed | -$22.2K | – | 5060 |
|
|
2016
Q3 | $28K | Sell |
853
-5,253
| -86% | -$160K | ﹤0.01% | 3658 |
|
|
2016
Q2 | $152K | Sell |
6,106
-177
| -3% | -$4.79K | ﹤0.01% | 2595 |
|
|
2016
Q1 | $154K | Sell |
6,283
-1,797
| -22% | -$41.6K | ﹤0.01% | 2512 |
|
|
2015
Q4 | $267K | Sell |
8,080
-17,085
| -68% | -$578K | ﹤0.01% | 2280 |
|
|
2015
Q3 | $824K | Buy |
25,165
+15,706
| +166% | +$668K | 0.01% | 1387 |
|
|
2015
Q2 | $501K | Buy |
+9,459
| New | +$344K | 0.01% | 1789 |
|
Group One Trading's ALDR Position: Q4 2019 in Review
Group One Trading sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 25,332 shares — an estimated $478K sold.
Group One Trading first reported a position in ALDR in Q2 2015 and held it in 16 quarters. The position peaked at $824K in Q3 2015. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Group One Trading reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Group One Trading sold 25,332 Alder Biopharmaceuticals shares in Q4 2019, an estimated $478K.
- Group One Trading first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 16 quarters.
- Group One Trading's Alder Biopharmaceuticals position peaked at $824K in Q3 2015.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Group One Trading's 13F filing for Q4 2019, filed 10 Feb 2020.